(Total Views: 384)
Posted On: 07/09/2021 2:17:29 PM
Post# of 148908
F.D.A. Requests Federal Investigation of Alzheimer’s Drug Approval
The agency’s acting head said a review should look into whether any interactions between agency staff and the drug developer, Biogen, broke F.D.A. rules.
https://www.nytimes.com/2021/07/09/health/adu...ation.html
(4)
(0)Scroll down for more posts ▼
